PRE-MARKET
The initial public offering price range for Molbio Diagnostics has been established, with a target of raising ₹940 crore. Subscription will begin on August 10, featuring a combination of fresh share issuance and offer for sale. Leading this endeavor are Kotak Mahindra Capital and IIFL Capital Services, assisted by Jefferies India and Motilal Oswal as book-running lead managers.
Molbio diagnostics' Rs 940 crore initial public offering opens August 10
Impact Score
Market Sentiment
→NeutralPrimary Sectors
The initial public offering price range for Molbio Diagnostics has been established, with a target of raising ₹940 crore. Subscription will begin on August 10, featuring a combination of fresh share issuance and offer for sale. Leading this endeavor are Kotak Mahindra Capital and IIFL Capital Services, assisted by Jefferies India and Motilal Oswal as book-running lead managers.
Key Highlights
The initial public offering price range for Molbio Diagnostics has been established, with a target of raising ₹940 crore.
Subscription will begin on August 10, featuring a combination of fresh share issuance and offer for sale.
Leading this endeavor are Kotak Mahindra Capital and IIFL Capital Services, assisted by Jefferies India and Motilal Oswal as book-running lead managers..
Source
Economic Times
Published
2h ago
Impact Score
70 / 100
Category
Indian Markets
Moderate near-term volatility expected while markets assess implications for Indian Markets.
What this means
No linked events found.